Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Laurence Booth, Jane L Roberts, Adam Conley, Nichola Cruickshanks, Thomas Ridder, Steven Grant, Andrew Poklepovic & Paul Dent. (2014) HDAC inhibitors enhance the lethality of low dose salinomycin in parental and stem-like GBM cells. Cancer Biology & Therapy 15:3, pages 305-316.
Read now
Read now
Zabi Wardak & Kevin S Choe. (2013) Molecular pathways and potential therapeutic targets in glioblastoma multiforme. Expert Review of Anticancer Therapy 13:11, pages 1307-1318.
Read now
Read now
Paul Dent. (2013) The multi-hit hypothesis in basal-like breast cancer. Cancer Biology & Therapy 14:9, pages 778-779.
Read now
Read now
Articles from other publishers (19)
Lena Hess, Verena Moos, Arnel A. Lauber, Wolfgang Reiter, Michael Schuster, Natascha Hartl, Daniel Lackner, Thorina Boenke, Anna Koren, Paloma M. Guzzardo, Brigitte Gundacker, Anna Riegler, Petra Vician, Claudia Miccolo, Susanna Leiter, Mahesh B. Chandrasekharan, Terezia Vcelkova, Andrea Tanzer, Jun Qi Jun, James Bradner, Gerald Brosch, Markus Hartl, Christoph Bock, Tilmann Bürckstümmer, Stefan Kubicek, Susanna Chiocca, Srividya Bhaskara & Christian Seiser. (2022) A toolbox for class I HDACs reveals isoform specific roles in gene regulation and protein acetylation. PLOS Genetics 18:8, pages e1010376.
Crossref
Crossref
Janaki Ramaiah Mekala, PrasannaSrinivasan Ramalingam, Nageswara Rao Moparthi & Vijay Kumar Kutala. 2022. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
3259
3286
.
Janaki Ramaiah Mekala, PrasannaSrinivasan Ramalingam, Nageswara Rao Moparthi & Vijay Kumar Kutala. 2021. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
1
28
.
Hyeok Jun Yun, Hee Jun Kim, Jungmin Kim, Sang Yong Kim, Hang-Seok Chang, Cheong Soo Park, Ho-Jin Chang & Ki Cheong Park. (2021) Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models. International Journal of Molecular Sciences 22:2, pages 536.
Crossref
Crossref
Alexandre Perla, Lívia Fratini, Paula S. Cardoso, Carolina Nör, André T. Brunetto, Algemir L. Brunetto, Caroline Brunetto de Farias, Mariane Jaeger & Rafael Roesler. (2020) Histone Deacetylase Inhibitors in Pediatric Brain Cancers: Biological Activities and Therapeutic Potential. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Jane L. Roberts, Andrew Poklepovic, Laurence Booth & Paul Dent. (2020) The multi-kinase inhibitor lenvatinib interacts with the HDAC inhibitor entinostat to kill liver cancer cells. Cellular Signalling 70, pages 109573.
Crossref
Crossref
Jiaqing Yi & Jiang Wu. (2018) Epigenetic regulation in medulloblastoma. Molecular and Cellular Neuroscience 87, pages 65-76.
Crossref
Crossref
Laurence Booth, Jane L. Roberts, Andrew Poklepovic, John Kirkwood & Paul Dent. (2017) HDAC inhibitors enhance the immunotherapy response of melanoma cells. Oncotarget 8:47, pages 83155-83170.
Crossref
Crossref
Laurence Booth, Jane L. Roberts, Cindy Sander, John Lee, John M. Kirkwood, Andrew Poklepovic & Paul Dent. (2017)
The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells
in vitro
and
in vivo
. Oncotarget 8:10, pages 16367-16386.
Crossref
Crossref
Zhiqiang Zhang, Yunmin Wang, Jiehan Chen, Qijia Tan, Caijun Xie, Cong Li, Wengang Zhan & Mei Wang. (2016) Silencing of histone deacetylase 2 suppresses malignancy for proliferation, migration, and invasion of glioblastoma cells and enhances temozolomide sensitivity. Cancer Chemotherapy and Pharmacology 78:6, pages 1289-1296.
Crossref
Crossref
Nestor Prieto-Domínguez, Raquel Ordóñez, Anna Fernández, Andres García-Palomo, Jordi Muntané, Javier González-Gallego & José L. Mauriz. (2016) Modulation of Autophagy by Sorafenib: Effects on Treatment Response. Frontiers in Pharmacology 7.
Crossref
Crossref
David Bakhshinyan, Maleeha A. Qazi, Neha Garg, Chitra Venugopal, Nicole McFarlane & Sheila K. Singh. 2015. Principles of Stem Cell Biology and Cancer. Principles of Stem Cell Biology and Cancer
145
167
.
Clara Penas, Vasileios Stathias, Bryce K. Allen & Nagi G. Ayad. 2015. Epigenetic Cancer Therapy. Epigenetic Cancer Therapy
317
337
.
Ana-Maria Marino, Jeroen Frijhoff, Raul Calero, Ninib Baryawno, Arne Östman & John Inge Johnsen. (2014) Effects of epigenetic modificators in combination with small molecule inhibitors of receptor tyrosine kinases on medulloblastoma growth. Biochemical and Biophysical Research Communications 450:4, pages 1600-1605.
Crossref
Crossref
Tobey J. MacDonald, Dolly Aguilera & Robert C. Castellino. (2014) The rationale for targeted therapies in medulloblastoma. Neuro-Oncology 16:1, pages 9-20.
Crossref
Crossref
Carolina N?r, Felipe A. Sassi, Caroline Brunetto de Farias, Gilberto Schwartsmann, Ana Lucia Abujamra, Guido Lenz, Algemir Lunardi Brunetto & Rafael Roesler. (2013) The Histone Deacetylase Inhibitor Sodium Butyrate Promotes Cell Death and Differentiation and Reduces Neurosphere Formation in Human Medulloblastoma Cells. Molecular Neurobiology 48:3, pages 533-543.
Crossref
Crossref
Hossein A. Hamed, Adly Yacoub, Margaret A. Park, Kellie Archer, Swadesh K. Das, Devanand Sarkar, Steven Grant, Paul B. Fisher & Paul Dent. (2013) Histone Deacetylase Inhibitors Interact with Melanoma Differentiation Associated-7/Interleukin-24 to Kill Primary Human Glioblastoma Cells. Molecular Pharmacology 84:2, pages 171-181.
Crossref
Crossref
Nelson S. YeeAbid A. KaziRosemary K. Yee. (2013) Translating Discovery in Zebrafish Pancreatic Development to Human Pancreatic Cancer: Biomarkers, Targets, Pathogenesis, and Therapeutics. Zebrafish 10:2, pages 132-146.
Crossref
Crossref
David T. W. Jones, Paul A. Northcott, Marcel Kool & Stefan M. Pfister. (2013) The Role of Chromatin Remodeling in Medulloblastoma. Brain Pathology 23:2, pages 193-199.
Crossref
Crossref